Zio AT ECG Monitoring System vs Aorta-CAD
AI Verdict
Choose Zio AT ECG Monitoring System if…
Choose Zio AT if you require continuous, long-term cardiac rhythm monitoring for up to 14 days to detect intermittent or asymptomatic arrhythmias. This system is ideal for patients where standard ECGs or shorter-term monitors have been inconclusive, providing comprehensive, AI-powered analysis for a more complete diagnostic picture.
View Zio AT ECG Monitoring System →Choose Aorta-CAD if…
Choose Aorta-CAD if your practice frequently utilizes chest X-rays and you need AI-powered assistance in identifying signs of Aortic Atherosclerosis and Aortic Ectasia. This tool is best suited for enhancing the accuracy and immediacy of frontline diagnostic imaging by seamlessly integrating into existing X-ray reading workflows for radiologists and primary care physicians.
View Aorta-CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio AT ECG Monitoring System | Aorta-CAD |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | Cloud-based (data analytics and clinician portal) | Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Aorta-CADAorta-CAD emphasizes seamless integration into existing X-ray reading workflows without requiring new PACS technology or costly re-training, suggesting a highly intuitive experience for clinicians. While Zio AT is praised for patient comfort compared to older monitors, its application process and potential for skin irritation are notable patient-side usability considerations.
Clinical Value
Aorta-CADAorta-CAD clearly demonstrates its clinical value with specific, quantifiable outcomes from a clinical study, showing a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta. While Zio AT offers significant value in long-term arrhythmia detection, it lacks similarly explicit, quantified outcome metrics in the provided information.
Pricing & Value
TieNeither the provided structured facts nor web searches disclose public pricing information for either the Zio AT ECG Monitoring System or Aorta-CAD. Without transparent pricing, it is impossible to conduct a head-to-head comparison of their financial value.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering cloud-based deployments with Business Associate Agreements (BAAs). Both also support integration into existing clinical workflows or EHR/EMR systems, indicating their suitability for healthcare organizations.
Innovation
Zio AT ECG Monitoring SystemWhile both utilize deep learning AI, Zio AT's innovation lies in its 'wear and forget' continuous, long-term ECG monitoring system, combining a novel wearable patch with wireless data transmission and AI analysis for extended periods. This approach represents a more significant advancement in patient monitoring methodology compared to AI-assisted interpretation of existing imaging.
Support & Docs
Aorta-CADAorta-CAD explicitly details comprehensive support offerings, including a direct phone number, email, 24/7 emergency support, and assistance with EMR integration, staff training, and ongoing administrative support. While Zio AT provides customer care and documentation, Aorta-CAD's listed support services appear more extensive and tailored for enterprise implementation and ongoing operations.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio AT ECG Monitoring System | Aorta-CAD |
|---|---|---|
| Name | Zio AT ECG Monitoring System | Aorta-CAD |
| Company | iRhythm Technologies, Inc. | Imagen Technologies |
| Description | The Zio AT ECG Monitoring System by iRhythm Technologies is an FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting. | Aorta-CAD by Imagen Technologies is an FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows. |
| Primary Function | Continuous, AI-powered ECG monitoring for long-term arrhythmia detection | AI software to assist in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays |
| Key Features (Example 1) | Wearable Zio AT patch for continuous ECG recording | Detects and highlights radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia |
| Key Features (Example 2) | FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection | Utilizes deep learning algorithms for analysis |
Videos
Demos, reviews, and walkthroughs featuring Zio AT ECG Monitoring System and Aorta-CAD.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio AT ECG Monitoring System or Aorta-CAD
Backers
Who funded each tool's parent company.